Abstract
Maternally inherited 15q11-q13 duplications are generally found to cause more severe neurodevelopmental anomalies compared to paternally inherited duplications. However, this assessment is mainly inferred from the study of patient populations, causing an ascertainment bias towards patients at the more severe end of the phenotypic spectrum. Here, we analyze the low coverage genome-wide cell-free DNA sequencing data obtained from pregnant women during non-invasive prenatal screening (NIPS). We detect 23 15q11-q13 duplications in 333,187 pregnant women (0.0069%), with an approximately equal distribution between maternal and paternal duplications. Maternally inherited duplications are always associated with a clinical phenotype (ranging from learning difficulties to intellectual impairment, epilepsy and psychiatric disorders), while paternal duplications are normal or associated with milder phenotypes (mild learning difficulties and dyslexia). This data corroborates the difference in impact between paternally and maternally inherited 15q11-q13 duplications, contributing to the improvement of genetic counselling. We recommend reporting 15q11-q13 duplications identified during genome-wide NIPS with appropriate genetic counselling for these pregnant women in the interest of both mothers and future children.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
The datasets generated during the current study are available from the corresponding author on reasonable request and within ethical constraints.
References
Bianchi DW, Chiu RWK. Sequencing of circulating cell-free DNA during pregnancy. N. Engl J Med. 2018;379:464–73.
Vermeesch JR, Voet T, Devriendt K. Prenatal and pre-implantation genetic diagnosis. Nat Rev Genet. 2016;17:643–56.
Pertile MD, Halks-Miller M, Flowers N, Barbacioru C, Kinnings SL, Vavrek D, et al. Rare autosomal trisomies, revealed by maternal plasma DNA sequencing, suggest increased risk of feto-placental disease. Sci Transl Med. 2017;9:eaan1240.
Van Opstal D, Van Maarle MC, Lichtenbelt K, Weiss MM, Schuring-Blom H, Bhola SL, et al. Origin and clinical relevance of chromosomal aberrations other than the common trisomies detected by genome-wide NIPS: Results of the TRIDENT study. Genet Med. 2018;20:480–5.
van der Meij KRM, Sistermans EA, Macville MVE, Stevens SJC, Bax CJ, Bekker MN, et al. TRIDENT-2: National Implementation of Genome-wide Non-invasive Prenatal Testing as a First-Tier Screening Test in the Netherlands. Am J Hum Genet. 2019;105:1091–101.
Brison N, Neofytou M, Dehaspe L, Bayindir B, Van Den Bogaert K, Dardour L, et al. Predicting fetoplacental chromosomal mosaicism during non-invasive prenatal testing. Prenat Diagn. 2018;38:258–66.
Brison N, Van Den Bogaert K, Dehaspe L, Van Den Oever JME, Janssens K, Blaumeiser B, et al. Accuracy and clinical value of maternal incidental findings during noninvasive prenatal testing for fetal aneuploidies. Genet Med. 2017;19:306–13.
Li R, Wan J, Zhang Y, Fu F, Ou Y, Jing X, et al. Detection of fetal copy number variants by non-invasive prenatal testing for common aneuploidies. Ultrasound Obstet Gynecol. 2016;47:53–57.
Brison N, Storms J, Villela D, Claeys KG, Dehaspe L, de Ravel T, et al. Maternal copy-number variations in the DMD gene as secondary findings in noninvasive prenatal screening. Genet Med. 2019;21:2774–80.
Van Den Bogaert K, Lannoo L, Brison N, Gatinois V, Baetens M, Blaumeiser B, et al. Outcome of publicly funded nationwide first-tier noninvasive prenatal screening. Genet Med. 2021;23:1137–42.
Kalsner L, Chamberlain SJ. Prader-Willi, Angelman, and 15q11-q13 Duplication Syndromes. Pediatr Clin North Am. 2015;62:587–606.
Butler MG. Imprinting disorders in humans: a review. Curr Opin Pediatr. 2020;32:719–29.
Aypar U, Brodersen PR, Lundquist PA, Brian Dawson D, Thorland EC, Hoppman N. Does parent of origin matter? Methylation studies should be performed on patients with multiple copies of the prader-willi/angelman syndrome critical region. Am J Med Genet Part A. 2014;164:2514–20.
Lusk L, Vogel-Farley V, Distefano C, Jeste S. Maternal 15q Duplication Syndrome In: Adam MP, Mirzaa GM, Pagon RA, et al., editors. GeneReviews®. Seattle, WA: University of Washington. 1993–2023 [Updated 2021 Jul 15]. 2016. https://www.ncbi.nlm.nih.gov/books/NBK367946/.
Beghi E, Giussani G, Bianchi E, Randazzo G, Sarcona V, Elia M, et al. A validation study of the clinical diagnosis of Dup15q syndrome: Which symptoms matter most? Seizure 2020;74:26–30.
Battaglia A. The inv dup(15) or idic(15) syndrome: A clinically recognisable neurogenetic disorder. Brain Dev. 2005;27:365–9.
Piard J, Philippe C, Marvier M, Beneteau C, Roth V, Valduga M, et al. Clinical and molecular characterization of a large family with an interstitial 15q11q13 duplication. Am J Med Genet Part A. 2010;152:1933–41.
Isles AR, Ingason A, Lowther C, Walters J, Gawlick M, Stöber G, et al. Parental Origin of Interstitial Duplications at 15q11.2-q13.3 in Schizophrenia and Neurodevelopmental Disorders. PLoS Genet. 2016;12:e1005993.
Urraca N, Cleary J, Brewer V, Pivnick EK, Mcvicar K, Thibert RL, et al. The interstitial duplication 15q11.2-q13 syndrome includes autism, mild facial anomalies and a characteristic EEG signature. Autism Res. 2013;6:268–79.
Al Ageeli E, Drunat S, Delanoë C, Perrin L, Baumann C, Capri Y, et al. Duplication of the 15q11-q13 region: Clinical and genetic study of 30 new cases. Eur J Med Genet. 2014;57:5–14.
Pinto D, Delaby E, Merico D, Barbosa M, Merikangas A, Klei L, et al. Convergence of genes and cellular pathways dysregulated in autism spectrum disorders. Am J Hum Genet. 2014;94:677–94.
Villela D, Che H, Van Ghelue M, Dehaspe L, Brison N, Van Den Bogaert K, et al. Fetal sex determination in twin pregnancies using non-invasive prenatal testing. npj Genom Med. 2019;4:15.
Bayindir B, Dehaspe L, Brison N, Brady P, Ardui S, Kammoun M, et al. Noninvasive prenatal testing using a novel analysis pipeline to screen for all autosomal fetal aneuploidies improves pregnancy management. Eur J Hum Genet. 2015;23:1286–93.
Raman L, Dheedene A, De Smet M, Van Dorpe J, Menten B. WisecondorX: improved copy number detection for routine shallow whole-genome sequencing. Nucleic Acids Res. 2019;47:1605–14.
Straver R, Sistermans EA, Holstege H, Visser A, Oudejans CBM, Reinders MJT. WISECONDOR: Detection of fetal aberrations from shallow sequencing maternal plasma based on a within-sample comparison scheme. Nucleic Acids Res. 2014;42:e31.
Battaglia A. The inv dup (15) or idic (15) syndrome (Tetrasomy 15q). Orphanet J Rare Dis. 2008;3:1–7.
Hogart A, Wu D, LaSalle JM, Schanen NC. The Comorbidity of Autism with the Genomic Disorders of Chromosome 15q11.2-q13. Neurobiol Dis. 2010;38:181–91. p.
FPS Public Health. Opinion no. 66 of 9 May 2016—non-invasive prenatal testing (NIPT). 2016 https://www.health.belgium.be/en/opinion-no-66-non-invasive-prenatal-testing-nipt (2016).
Belgian Society for Human Genetics. Belgian guidelines for managing incidental findings detected by NIPT. 2021. https://www.college-genetics.be/nl/voor-de-professionele/good-practice-et-richtlijnen-voor-beroepsbeoefenaars/richtlijnen.html.
DiStefano C, Wilson RB, Hyde C, Cook EH, Thibert RL, Reiter LT, et al. Behavioral characterization of dup15q syndrome: Toward meaningful endpoints for clinical trials. Am J Med Genet A. 2020;182:71–84.
Acknowledgements
We would like to thank all participating women, clinicians and laboratory staff. We also thank the Genomics Core (KU Leuven) for their sequencing and bioinformatic support.
Funding
Funding for this study is provided by the KU Leuven (C14/22/125) and the FWO-SBO-MICADO S003422.
Author information
Authors and Affiliations
Contributions
Conceptualization: IP, KVDB, KD, JRV. Investigation and methodology: IP, KVDB, KD, JRV. Formal analysis: IP. Visualization: IP. Data curation: IP, NB, LV, KJ, BB, MB, SJ, BM, BD, NF, KVB, AVDB, CM, JD, SB, AM. Supervision: KVDB, KD, JRV. Writing—original draft, review, and editing: IP, KJ, MB, BM, NF, KVDB, KJ, KD, JRV.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethical approval
This study is approved by the Ethics Committee Research of University Hospitals Leuven (S66428).
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Parijs, I., Brison, N., Vancoillie, L. et al. Population screening for 15q11-q13 duplications: corroboration of the difference in impact between maternally and paternally inherited alleles. Eur J Hum Genet 32, 31–36 (2024). https://doi.org/10.1038/s41431-023-01336-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41431-023-01336-6
This article is cited by
-
Managing genetic information sharing at family and population level
European Journal of Human Genetics (2024)